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[571 ABSTRACT 
Biocompatible polymeric microspheres having an aver- 
age diameter below about 3 microns and having density 
at least 15% greater or lesser than organic cells and 
having covalent binding sites are provided in accor- 
dance with this invention. The microspheres are ob- 
tained by copolymerizing a hydroxy or amine substi- 
tuted acrylic monomer such as hydroxyethylmethacry- 
late with a light or dense comonomer such as a 
fluoromonomer. A lectin or antibody is bound to the 
hydroxy or amine site of the bead to provide cell speci- 
ficity. When added to a :ell suspension the marked 
bead will specifically label the cell membrane by bind- 
ing to specific receptor sites thereon. The labelled 
membrane can then be separated by density gradient 
centrifugation. 




CELL SPECIFIC, VARIABLE DENSITY, POLYMER 
MICROSPHERES 
ORIGIN OF THE INVENTION 
The invention described herein was made in the per- 
formance of work under a NASA contract and is sub- 
ject to the provisions of Section 305 of the National 
Aeronautics and Space Act of 1958, Public Law 
83-568 (72 Stat. 435; 42 USC 2457). 
BACKGROUND OF THE INVENTION 
1. Field of the Invention 
The present invention relates to uniformly sized poly- 
meric microspheres, to methods of making the micro- 
spheres and to their use in labelling cell surfaces. 
2. Description of the Prior Art 
The isolation and characterization of cell membranes 
and their components is essential for an understanding 
of the role in which surface membranes play in regulat- 
ing a wide variety of biological and immunological 
activities. The present techniques used for this purpose 
are unsatisfactory. 
Most biological studies depend on the knowledge of 
cell membrane structure and its surface properties 
because cell functions are controlled by surface inter- 
actions between cell membranes and their environ- 
ment. Thus the cell membrane properties determine 
the uptake of nutrients, growth, adhesion to other cells 
or artificial surfaces, removal of foreign particles 
(phagocytosis) etc. Of particular interest are the cell 
membrane receptors of normal and transformed cells 
and the interaction of specific sites on the membrane 
with chemotherapeutic or cytotoxic agents. Informa- 
tion on this interaction is necessary for practical appli- 
cations, e.g., development of diagnostic tests or de- 
struction of diseased cells. The separation of cell mem- 
branes and the isolation of cell receptors is the first step 
in the study of their properties or their interaction with 
natural or foreign elements. Although several methods 
of membrane separation are at present used and new 
methods are being investigated, none of them is satis- 
factory and a good technique for isolation of specific 
sites on the membrane surface is non-existent. 
Knowledge of the nature, number and distribution of 
specific receptors on cell surfaces is of central impor- 
tance for an understanding of the molecular basis un- 
derlying such biological phenomena as cell-cell rec- 
ognition in development, cell communication and regu- 
lation by hormones and chemical transmitters, and 
differences in normal and tumor cell surfaces. In previ- 
ous studies, the localization of antigens and carbohy- 
drate residues on the surface of cells, notably red blood 
cells and lymphocytes, has been determined by bond- 
ing antibodies or lectins to such macromolecules as 
ferritin, hemocyanin or peroxidase which have served 
as markers for transmission electron microscopy. With 
advances in high resolution scanning electron micros- 
copy (SEM ), however, the topographical distribution 
of molecular receptors on the surfaces of cell and tissue 
specimens can be readily determined by similar histo- 
chemical techniques using newly developed markers 
resolvable by SEM. 
Recently commercially available polystyrene latex 
particles have been utilized as immunologic markers 
for use in the SEM technique. The surface of such 
polystyrene particles is hydrophobic and hence certain 
types of macromolecules such as antibodies are ad- 
L 
sorbed on the surface under carefully controlled condi- 
tions. However, such particles stick non-specifically to 
many surfaces and molecules and this seriously limits 
their broad application. Though these particles, while 
5 of the proper density for separating adsorbed or la- 
belled membranes from other membranes are un- 
charged and are not capable of any derivitization by 
ionic or covalent bonding of protein and other biologi- 
cal molecules, and are thus limited in use to generalized 
The preparation of small, stable, spherical particles 
which are bio-compatible, Le., do not interact non- 
specifically with cells or other biological components 
and which contain functional groups to which specific 
15 proteins and other bio-chemical molecules can be co- 
valently bonded is disclosed in copending application 
Ser. No. 434,124, filed Jan. 17, 1974, now U.S. Pat. 
No. 3,957,741, issued May 18, 1976. 
The hydroxyl or amino groups can be activated by 
20 cyanogen bromide for covalent bonding of proteins and 
other chemicals containing amino groups to the poly- 
meric latex. Methacrylic acid residues which impart a 
negative charge onto the particles are likely to prevent 
non-specific binding to cell surfaces and to provide 
25 carboxyl groups to which a variety of bio-chemical 
molecules can be covalently bonded using the carbodi- 
imide method. Cross-linking of the polymeric matrix is 
essential to maintain the stability and size of the parti- 
cles in both aqueous solution and in organic solvents 
30 commonly used in the fixation and dehydration of bio- 
logical specimens for electron or light microscopy. 
The polymeric microspheres ranging in diameter 
from 300 to 2000A have been successfully utilized as 
biocompatible immunochemical markers of red blood 
35 cells and lymphocytes in scanning electric and light 
microscopy. However, the density of the microspheres 
is so close to that of the cell membranes that isolation 
of the cell membranes or bound receptor sites is not 
possible. 
SUMMARY OF THE INVENTION 
Amine-, hydroxyl- and/or carboxyl-substituted mi- 
crospheres are provided in accordance with the inven- 
tion having a density of at least 1.30 glcc, preferably 
45 above 1.40 g/cc, or a density below 1.15 g/cc prefer- 
ably below 1.08 glcc. The density of cellular organelles 
is of the order of about 1.20 glcc. The beads of the 
invention being considerably smaller than biological 
cells and being capable of binding a protein conjugate 
SO can attach to specific receptor sites on the surface of 
the cell membrane and after fragmentation of the mem- 
brane can be recovered by sedimentation or centrifuga- 
tion techniques. 
The microspheres will find use in lectin, antibody or 
55 sugar derivatized forms. They can be used to isolate 
membrane fragments enriched for the appropriate cel- 
lular ligand(s) which bind to the substance covalently 
attached to the bead. The microspheres currently avail- 
able permit no more than an assessment of the cellular 
60 materials which can be labeled by agents which cannot 
penetrate membranes, thus greatly restricting the 
amount of useful information obtained. 
The microspheres can be utilized to yield a biochemi- 
cal mapping of the membrane with respect to assess- 
65 ment of surface receptors which can redistribute in the 
plane of the membrane in response to a matrix contain- 
ing rigidly displayed ligands. This will be useful in de- 
termining the contributing roles of the restriction of 





movement of certain surface receptors to oncogenic tion, as disclosed in copending application Ser. No. 
transformation of cells. Other applications include the 634,935, filed concurrently herewith, small micro- 
isolation of differentiated regions of cell surface mem- spheres of more uniform diameter are formed. 
branes, and studies of this nature would be of great The first covalently bondable monomer is suitably a 
utility in areas such as development biology. 5 primary amine, carboxyl, or hydroxyl substituted 
acrylic monomer and should comprise at least 10% by The microspheres are synthesized by free radical 
initiated emulsion polymerization or high energy radia- 
tion induced copolymerizaton o f  a first ethylenically 
unsaturated monomer containing a covalently bond- 
able moiety such as hydroxyl, primary amine or car- 
boxyl, and ethylenically unsaturated comonomer hav- 
ing a density differing from the monomer by at least 15 
percent and a cross-linking agent to form small, round, 
microspheres at least 80% of which have a uniform 
diameter below 5 microns, and preferably below 1 
micron, suitably 300 to 2000 A. The microspheres have 
a density above 1.3 or below 1.15 glcc, are hydrophilic, 
hydrolytically stable, are biocompatible and have of 
sufficient mechanical strength to be useful as an absor- 
weight of the monomer mixture, generally from 20 to 
60% thereof. Exemplary monomers are acrylamide, an 
hydroxy lower alkyl acrylate an amino lower alkyl acry- 
late, acrylic acid, methacrylic acid or the like. Repre- 
sentative monomers may be selected from compounds 
of the formula: 
CH, 0 
II  II 5 
Rl-C-C-O-R2-Z 
where R' is hydrogen or lower alkyl of 1-8 carbon 
atoms, RZ is alkylene of 1-12 carbon atoms, Z is OH or Y 
bent in column or film chromotography, gel filtration 20 RY-N-R4 where R3 or R4 are H, lower alkyl or lower 
and Permeation, separation and analysis. The micro- alkoxy. 2-hydroxyethylmethacrylate, 3-hydroxypropyl 
spheres are of characterized structure, of Out- methacrylate, 2-dimethylaminoethyl methacrylate and 
standing purity and the hydrophilic properties, size and 2-aminoethyl methacrylate are readily available com- 
mechanical properties can be systematically varied by mercially. 
selection of monomer and polymerization conditions. 25 Minor amounts of o.35%, suitably 10-25% by weight 
The microspherical beads containing hydroxyl, car- of the mixture may comprise a compatible 
boxyl Or amine groups can be bonded to comonomer such as a lower alkyl methacrylate, acrylic antibodies and other biological materials and are useful or met)lacrylic acid, styrene or vinyl toluene. as specific cell surface markers for scanning electron The cross-linking agent is present in the monomer microscopy. The particles are found to bind to hor- 30 mixture in an amount from 1 to 10% and is a liquid mones, toxins, lectins, and other molecules and have 
application in the detection and localization of a vari- 
ety of cell surface receptors. Particles tagged with flue- 
polyunsaturated compound such as a diene or a triene 
capable of addition pobmerization with the unsatu- 
rescent dye or radioactive molecules serve as sensitive rated group Of the monomer* are 
markers for fluorescent microscopy and as reagents for 35 low r d t m ~ l a r  weight liquid PolYvinYl compounds such 
quantitative study of cell surface components by cova- , as ethylene glycol dimethacrylate (EGD), divinYl hen- 
lently bonding lectins, antigens, hormones and other zene, trimethyl01 Propane trimethacrylate and N,N'- 
molecules to these spheres, and detection and localiza- methylene-bis-acrylamide. 
tion of specific carbohydrate residues. Antibodies, hor- A commercial form (95%) of hydroxyethylmethacry- 
mone receptors and other specific cell surface compo- 40 late (HEMA) and hydroxypropyl methacrylate 
nents can also be determined. These reagents also have (HPMA) as supplied, contains small amounts of meth- 
application in highly sensitive radioimmune assays, as acrylic acid, hydroxyalkoxyalkylmethacrylate and 
visual markers for fluorescent and transmission elec- dimethacrylates - ethylene dimethacrylate in HEMA 
tron microcsopy, for radioactive quantitation of spe- and propylene dimethacrylate in HPMA. HPMA is 
cific cell surface receptors and as potential therapeutic 45 generally a mixture in which the principal monomers 
reagents. comprise 68-75% of 2-hydroxypropyl and 25-32% of 
Technique for isolation of Cell membranes and mem- 1 -methyl-2-hydroxyethylmethacrylate. 
brane receptors comprises the steps of covalently The variable density commonomer is present in the 
bonding an antibody or antigen molecule to the micro- monomer mixture in an amount sufficient to raise or 
spheres* The bonded microspheres are then to be 50 lower the density to the desired range. It is to be real- 
added to cells to label and bind to specific ized that the cross-linked microspheres have a greater 
receptor* Or antibody, sites On the mem- density than the monomers. The acrylic monomers and 
merits by nitrogen decompression9 homogenization Or 
brane. The labeled cells are then disrupted into frag- 
other standard procedure. The membrane fragments 55 
are then centrifuged to equilibrium on linear density 
gradients. 
These and other attendant advantages of the inven- 
better understood by reference to the following de- 60 
tailed descriptions. 
cOmOnOmerS generally have a density of about o.9 to 
of about 1.24 glcc. If one half of the hydroxyethylmeth- 
acrylate monomer is replaced with a monomer such as 
trifluoroethyl methacrylate which has a density of 1.16 
1.0 g/cc and they form microspheres having a density 
tion will become apparent as the invention becomes d c c ,  about 3O% higher, the resulting microsphere 
have a density Of about 1.42* 
The heaviest known comonomers have a density of 
about 1.6 glcc and the lightest about 0.78 glcc. Thus 
the minimum amount of variable density of comono- 
mer should be about 25% by weight. The maximum 
The total monomer concentration is maintained be- 65 amount is only limited by the amount of first monomer 
and combatible reactivity considerations. Representa- 
tive variable density comonomers are provided in the 
following table. 
DESCRIPTION OF THE PREFERRED 
EMBODIMENTS 
tween 1 to 40% by weight preferably from 3 to 30% by 
weight of the polymerization mixture. By utilizing low 




Comonomer Density, glcc 
Trifluoroethyl methacrylate (TFEM ) 1.16 
Pentafluorostyrene 1.412 
Vinyl ethyl ketone 0.985 
Vinyl ethyl ether 0.76 
Vinyl iodide 
Hexafluoropropyl methacrylate 1.16 
Methacryloxymethylpentamethyl disiloxane 0.903 
1.3-Bis (methacryloxymethy1)- 0.996 
disiloxane 
Vinyl bromide I .5 
Emulsion polymerization is conducted at tempera- 
tures from about 60" to 1203 C with agitation in pres- 
ence of an inert gas such as nitrogen or argon in the 
presence of an emulsifier and free radical inhibitor. 
The monomers, emulsifier and inhibitor are introduced 
into distilled water in a container. The container is 
immersed in a heated bath. In about 1 hour nearly 
quantitative yields are achieved. Emulsifier and other 
ionic impurities are removed from the latex suspension 
on a mixed-bed ion exchange column and the micro- 
sphere particles are then dried. The density of the parti- 
cles is then determined by centrifugation at 100,000 g 
for 12 hours on a linear sucrose gradient. The diameter 
of the particles was measured by transmission and scan- 
ning electron microscopy. 
The surface active emulsifying agent is preferably 
present in an amount below 10% by weight of the 
monomer mixture, typically from 2-5% thereof, to 
minimize the after treatment for removal of the agent 
from the microsphere suspension. Suitable agents are 
ionic materials such as sodium dodecyl sulfate (SDS), 
sodium lauryl sulfate, sodium stearate or non ionic 
materials such as polyethylene oxide lauryl ether. 
The free radical initiator may be present in amounts 
from 0.01 to 3% by weight of the monomer mixture and 
may be a persulfate, peroxide, azo or redox material. 
Suitable materials are ammonium persulfate (AP), 
benzoyl peroxide, lauroyl peroxide, t-butyl hydroper- 
oxide, t-butyl perbenzoate, cumene peroxide, azodiiso- 
butyronitrile, azodiisobutyro-amide or mixtures thereof 
with reducing agents such as sodium bifulfite or sodium 
thiosulfate. 
Examples of practice follow: 
EXAMPLE 1 
0.9 grams of 2-hydroxethyl methacrylate (HEMA), 
, 
6 
Density of beads produced > 1.4 1 as determined on a 
sucrose gradient. 
EXAMPLE 3 
5 The same conditions as Example 1 were followed 
except for the following monomer composition: 
2-hydroxyethyl methacrylate 0.7 g 
methacrylic acid 0.7 g 
ethylene glycol dimethacrylate 0.49 g 
l o  trifluoroethyl methacrylate 5.11 g 
The density was 1.3 1 g as determined on a sucrose 
15 gradient. 
EXAMPLE 4 
Identical conditions to Example 1 except for the 
following monomer composition: 
20 
HEMA 1.4 g 
MAA 0.7 g 
TFEM 4.41 g 
EGD .49 g 
25 
Density was 1.305 g as determined on a sucrose gra- 
dient. 
EXAMPLE 5 
following monomer composition: 
30 Identical conditions to Example 1 except for the 
HEMA 2.1 g 
TFEM 3.71 g 
EGD 0.49 g 
35 MAA 0.7 g 
Density was 1.265 g as determined on a sucrose gra- 
Flourescent or radioactive tagged beads can be pre- 
pared by covalently binding glycine or dansyl-e-lysine 
by the cyanogen bromide procedure disclosed by Cua- 
trecasas, 1970, J. Biol. Chem. 245:3059 and as dis- 
45 closed in copending application Ser. No. 634,935 filed 
concurrently herewith, the disclosure of which is incor- 
porated herein by reference. 
An aqueous suspension of the beads of Example 1 
40 dient. 
0.3 grams of methacrylic acid (MAA), 1.5 grams of 5o (20-55 mg/ml) is adjusted to pH 10.5 and is actiiated 
hexafluoroisopropyl methacrylate and 0.3 g of bis- with CNBr ( 10-20 mdml of suspension) at 25" c. The 
acrylamide were combined with distilled water to form pH of the reaction mixture is maintained at 10.5 with 1 
a 3% total monomer solution. 0.12 grams of SDS and N NaCH After 10-15 minutes, the activated beads are 
0.012 g of AP were added and the container inbited added to an equal volume of 5mM dansyl-e-lysine or 
with argon was placed in a tumbling container and 55 ['HI glycine in 0.2 M carbonate buffer at PH 10 and 
inserted in a 98" C bath for 1 hour. the suspension is stored for 12 hours at 4" C. Uncou- 
400A diameter microspheres in 99% yield having a pled reagents are removed by extensive dialysis against 
density of 1.46 g/cc were recovered. Density was deter- several charges of 0.1 M NaCl. 
mined by means of a cesium chloride density gradient. Derivatized beads can be prepared by bonding e- 
60 aminocaproic acid or diaminoheptane to the beads by 
EXAMPLE 2 using the carbodiimide reaction as disclosed by Good- 
friend et al.; Science (Wash. D.C.) 144: 1344. 10 mg of 
1 -ethyl-3-( 3-dimethyl aminopropy1)-carbodiimide 
(EDC) is added with stirring to 5 ml of bead suspension 
65 (25 mglml) suspended in 0.01 M diaminoheplane or 
0.01 M e-aminocaproic acid at pH 6-7 and 4" C. After 
stirring for 2 hours in the cold, the suspension is ex- 
haustively dialyzed against 0.1 M NaCI. 
The same conditions as Example 1 were followed 
except that the following monomers were used: 
trifluoroethyl methacrylate 6.51 g 




For use in cell surface-labeling experiments, purified ture including at least 10% by weight first ethylenically 
goat antirabbit IgG antibodies can be covalently unsaturated monomer containing at least one substitu- 
bonded to the beads by either the carbodiimide or ent selected from hydroxyl, carboxyl or amino, at least 
glutaraldehyde method. In the carbodiimide reaction, 25% by weight of a second ethylenically unsaturated 
10 mg of EDC are added to 50 mg of e-aminocaproic 5 comonomer having a density differing from the first 
acid derivatized latex and 1 mg of antibody in 2 ml of monomer by at least 15%, and 1-20% of a polyunsatu- 
0.1 M NaCl at pH 7.0 and 4" C. After 2 h the coupling rated cross-linking agent. 
reaction is stopped by the addition of 0.2 ml of 0.1 M 2. A composition according to claim 1 in which the 
glycine PH 8.0. Goat antirabbit k G  ( 1-2 mg) first monomer is a substituted acrylic monomer present 
is added to 50 mg of activated latex beads in 5 ml of 10 in the mixture in an from 20 to 60% by weight. 
0.01 phosphate buffer at pH 7.0 and the suspension is 3. A composition according to claim 2 in which the 
stirred for 5 hours at 25" C. The antibody-latex conju- beads are hydrophilic, swellable, porous, uniformly 
lows: The reaction suspension is layered onto a gradi- form diameter below microns. 
ent consisting of a 58% (wtlwt) sucrose solution over- 15 
gate is separated from the antibody as fol- shaped round beads, at least 80% of which have a uni- 
4. A composition according to claim 3 in which the layered with lo% 
with O.O1 
buffered at pH 8.0 
glycine. After centrifugation at loo,ooo g 
first monomer is selected from acrylamide, hydroxy- 
lower alkyl acrylates, amino-lower alkyl acrylates, for 3 hours in a Beckman SW-27 rotor (Beckman In- 
latex conjugate is collected at the interface between 58 20 first 
and 10% sucrose solutions. This procedure is repeated 
to insure complete removal of unbound antibody. Fi- 
nally, the antibody-latex conjugate is dialyzed exten- 
sively against PBS at pH 7.4. Large aggregates are 
and the conjugate (15-20 mglml) stored at 4" C. 
These new reagents offer a number of advantages where R' is hydrogen or lower alkyl of 1-8 carbon 
and applications for the study of cell surfaces, for im- atoms, RZ is alkylene of 1-1 2 carbon atoms, Z is OH or 
munodiagnosis and immuno-therapy: ( a )  Latex beads R3-Nl-R4 where R l  or R4 are H, lower alkyl or lower 
can be synthesized in a wide range of sizes, densities 30 alkoxy. 
and compositions to suit particular requirements and 6 .  A composition according to claim 5 in which the 
can be stored indefinitely. (b) Biological molec~~les first monomer is selected from 2-hydroxyethyl metha- 
such as antibodies, lectins, hormones, and toxins can be crylate, 3-hydroxyptopyl-methacrylate, 2-dime- 
bound to the latex beads by any of a variety of standard thylaminoethylmethacrylate and 2-aminoethylmetha- 
chemical procedures for use in the identification of 35 crylate. 
specific populations of cells, as well as in the detecton . 7. A composition according to claim 2 in which the 
and localization of specific cell surface receptors. How- cross-linking agent is a po~yvinyl diene or triene caps- 
acrylic acid or methacrylic acid. struments, Inc', Spinto Div., Palo Calif.), the 5. A composition according to claim 4 in which the 
is selected from compounds of the for- 
mula: 
CH, 0 
It I1 removed by centrifugation at 4,000 g for 10 minutes 25 RL-C- C-0-R2-Z 
ever, receptors which are densely distributed on the 
surface of cells cannot be mapped to a high 
ble of addition polymerization with the first monomer 
and comonomer and is present in the monomer mixture 
with these markers due to the relatively large size of the 40 in an amount from 5-15% by weight. 
latex beads. (c) Different sizes of beads can be used in in which the 
multiple-labeling experiments and in conjunction with cross-linking agent is selected from ethylene glycol 
beads the size of ferritin and hemocyanin, i.e., 150-350 trimethacrylate, and N,N~-methylene-bis-acrylamide. A in diameter, can serve as markers for transmission 45 in which the 
electron microscopy as well as in high resolution scan- comonomer is present in the monomer mixture in an 
amount above 40% by weight to 80% by weight. ning electron microscopy; beads larger than 0.2 pm in diameter can be used with ordinary light microscopy. 
(dl  These microspheres can Serve as highly sensitive 10. A composition according to claim 9 in which the 
fluorescent probes and quantitative reagents for bio- 50 comonomer contains at least three fluorine atoms. 
chemical and immunolog~cal studies. Binding fluores- 11. A composition according to claim 9 in which the 
cent dyes or radioactive molecules to the microspheres from hexafluoroisopropyl 
instead of to the antibodies permits a high degree of methacrylate, trifluoroethyl methacrylate, penta- 
ation and separation of specific receptor sites on the tamethyl siloxane and 1,3-bis-( methacryloxymethy1)- 
surface of the cell. disiloxane. 
It is to be realized that only preferred embodiments 12. A method of forming a suspension of polymeric 
of the invention have been described and that numer- beads having a density less than 1.15 g/CC Or greater 
ous substitutions, alterations and modifications may be 60 than 1.30 g/CC and an average dkmeter below 5 mi- 
made without departing from the spirit and scope of crons comprising the steps of: 
this invention as defined in the following claims. forming an ethylenically unsaturated monomer mix- 
ture consisting essentially of at least 10% by weight 
first ethylenically unsaturated monomer containing 
at least one substituent selected from hydroxyl, 
carboxyl or amino, at least 25% by weight of a 
second ethylenically unsaturated comonomer hav- 
ing a density differing from the first monomer by at 
8. A composition according to claim 
different types Of microscopy' For dimethacrylate, divinyl benzene, trimethyl01 propane 
9. A composition according to claim 
comonomer is 
tagging without adversely affecting the antibody activ- fluorostyrene, vinyl ethyl ketone, vinyl ethyl ether, 
ity. (e) The variable density beads permits fraction- 5 5  vinyl iodide, vinyl bromide, methacryloxy-methylpen- 
What is claimed is: 
1. A composition consisting essentially of a suspen- 
sion of polymeric beads having an average diameter 65 
below 5 microns, having a density less than 1.15 glcc or 
greater than 1.30 glcc and comprising the cross-linked 
product of an ethylenically unsaturated monomer mix- 
4.035,3 16 
9 
least 15%, and 1-20% of a polyunsaturated cross- 
linking agent; and 
addition polymerizing the mixture to form said sus- 
pension of beads. 
13. A method according to claim 12 in which the first 
monomer is present in the mixture in an amount from 
20 to 60% by weight and is selected from acrylamide, 
hydroxy-lower alkyl acrylates, amino-lower alkyl acryl- 
ates, acrylic acid or methacrylic acid, the cross-linking 
agent is present in an amount from 5-15% by weight 
and is selected from ethylene glycol dimethacrylate, 
divinyl benzene, trimethylol propane trimethacrylate, 
and N,N'-methylene-bis-acrylamide, and the comono- 
mer is present in the mixture in an amount from 
40-80% by weight and is selected from hexafluoroiso- 
propyl methacrylate, trifluoroethyl methacrylate, pen- 
tafluorostyrene, vinyl ethyl ketone, vinyl ethyl ether, 
10 
vinyl iodide, vinyl bromide, methacryloxy-methylpen- 
tamethyl siloxane and 1,3-bis-( methacryloxymethy1)- 
disiloxane. 
14. A method according to claim 13 in which the 
polymerization is conducted by aqueous emulsion poly- 
merization of said monomer mixture and the total 
monomer content is from 3-40% by weight of the poly- 
merization composition. 
15. A composition according to claim 9 in which the 
comonomer is selected from vinyl fluorides, vinyl ke- 
tones, vinyl ethers, vinyl iodides, vinyl bromides, and 
vinyl siloxanes. 
16. A protein specific reagent comprising the bead 
15 composition of claim 1 covalently bonded to a conju- 
gate of said protein. * * * * *  
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